Mechanistically, TFAP2A directly binds to the CD133 promoter to ignite tumor stem-like properties in HCC cells and synergizes with periostin/TGFβ1 positive feedback loop to further boost tumor stemness [28]. Here, TFAP2A is linked to neoplasm.